Home › Agent Hub › Agent Tools › Part D coverage by drug › NovoLog Mix
Agent Tools
NovoLog Mix is a brand of insulin aspart protamine, human / insulin aspart, human. What agents check before quoting it: how many 2027 Part D plans cover it, on which tier, with what restrictions and copays, by plan type, carrier and state.
In 2027, 3,948 of 5,492 Medicare Part D and Medicare Advantage drug plans (71.9%) list NovoLog Mix on their formulary, across 211 of 286 formularies. The most common placement is tier 3 (3,382 plans, 85.7% of those covering it). 0 of the covering plans require prior authorization (0%), 0 step therapy and 330 a quantity limit. Generic insulin aspart, human is on 5,262 of 5,492 plans (95.8%).
442 covering plans charge a flat copay for a 30-day supply at a preferred retail pharmacy after the deductible — median $30, 165 of them $0; 3,506 charge coinsurance instead — median 20% of the drug's cost. Covered insulin is capped at $35 for a month's supply.
NovoLog Mix has a Medicare negotiated price (maximum fair price) of $119 for a 30-day supply, which applies. The negotiated price lowers what the plan pays; the member's copay or coinsurance still follows the plan's tier.
2026: 4,297 of 5,496 plans covered it (78.2%); 2027: 3,948 of 5,492 (71.9%).
Of 4,367 plans offered in both years, 0 added it to the formulary and 259 dropped it.
Among plans covering it both years, 35 moved it to a higher tier and 245 to a lower one; 0 added prior authorization and 0 removed it.
| Tier | Plans |
|---|---|
| Tier 1 | 104 |
| Tier 2 | 409 |
| Tier 3 | 3,382 |
| Tier 4 | 20 |
| Tier 5 | 10 |
| Tier 6 | 23 |
| Plan type | Plans covering | Share | Prior auth |
|---|---|---|---|
| Stand-alone Part D (PDP) | 277 of 323 | 85.8% | 0% |
| Medicare Advantage with drugs (MA-PD) | 2,255 of 3,200 | 70.5% | 0% |
| Special needs plans (SNP) | 1,416 of 1,969 | 71.9% | 0% |
| Carrier | Plans covering | Usual tier | Prior auth |
|---|---|---|---|
| Humana | 846 of 846 | Tier 3 | 0 |
| UnitedHealthcare | 39 of 830 | Tier 3 | 0 |
| Devoted Health | 728 of 728 | Tier 3 | 0 |
| Aetna Medicare | 631 of 631 | Tier 3 | 0 |
| Wellcare | 268 of 268 | Tier 2 | 0 |
| HealthSpring | 40 of 226 | Tier 3 | 0 |
| Kaiser Permanente | 0 of 112 | No tier listed | 0 |
| SCAN Health Plan | 0 of 83 | No tier listed | 0 |
| Highmark Blue Cross Blue Shield or Highmark Blue Shield | 80 of 80 | Tier 3 | 0 |
| Alignment Health Plan | 77 of 77 | Tier 3 | 0 |
| Anthem Blue Cross and Blue Shield | 74 of 74 | Tier 3 | 0 |
| Wellpoint | 63 of 63 | Tier 3 | 0 |
| Priority Health Medicare | 40 of 40 | Tier 3 | 0 |
| CarePlus Health Plans, Inc. | 37 of 37 | Tier 2 | 0 |
| Zing Health | 36 of 36 | Tier 3 | 0 |
| Capital Blue Cross | 27 of 35 | Tier 3 | 0 |
| Prominence Health Plan | 29 of 29 | Tier 3 | 0 |
| Medica | 0 of 27 | No tier listed | 0 |
| Anthem HealthKeepers | 26 of 26 | Tier 3 | 0 |
| Blue Cross Blue Shield of Michigan | 26 of 26 | Tier 3 | 0 |
| State | Plans covering | Share |
|---|---|---|
| Alabama | 77 of 114 | 67.5% |
| Alaska | 8 of 9 | 88.9% |
| American Samoa | 1 of 1 | 100% |
| Arizona | 112 of 147 | 76.2% |
| Arkansas | 64 of 85 | 75.3% |
| California | 219 of 397 | 55.2% |
| Colorado | 67 of 106 | 63.2% |
| Connecticut | 46 of 54 | 85.2% |
| Delaware | 32 of 43 | 74.4% |
| District of Columbia | 4 of 12 | 33.3% |
| Florida | 419 of 545 | 76.9% |
| Georgia | 103 of 149 | 69.1% |
| Guam | 1 of 1 | 100% |
| Hawaii | 37 of 50 | 74% |
| Idaho | 27 of 45 | 60% |
| Illinois | 95 of 132 | 72% |
| Indiana | 114 of 138 | 82.6% |
| Iowa | 51 of 64 | 79.7% |
| Kansas | 64 of 84 | 76.2% |
| Kentucky | 96 of 121 | 79.3% |
| Louisiana | 103 of 125 | 82.4% |
| Maine | 41 of 52 | 78.8% |
| Maryland | 31 of 49 | 63.3% |
| Massachusetts | 56 of 89 | 62.9% |
| Michigan | 168 of 182 | 92.3% |
| Minnesota | 25 of 63 | 39.7% |
| Mississippi | 75 of 104 | 72.1% |
| Missouri | 129 of 170 | 75.9% |
| Montana | 23 of 27 | 85.2% |
| Nebraska | 37 of 51 | 72.5% |
| Nevada | 72 of 100 | 72% |
| New Hampshire | 19 of 25 | 76% |
| New Jersey | 56 of 73 | 76.7% |
| New Mexico | 35 of 68 | 51.5% |
| New York | 170 of 215 | 79.1% |
| North Carolina | 132 of 176 | 75% |
| North Dakota | 14 of 26 | 53.8% |
| Northern Mariana Islands | 1 of 1 | 100% |
| Ohio | 114 of 171 | 66.7% |
| Oklahoma | 59 of 81 | 72.8% |
| Oregon | 70 of 92 | 76.1% |
| Pennsylvania | 252 of 323 | 78% |
| Puerto Rico | 23 of 64 | 35.9% |
| Rhode Island | 14 of 29 | 48.3% |
| South Carolina | 69 of 89 | 77.5% |
| South Dakota | 18 of 30 | 60% |
| Tennessee | 117 of 156 | 75% |
| Texas | 295 of 407 | 72.5% |
| U.S. Virgin Islands | 1 of 1 | 100% |
| Utah | 37 of 53 | 69.8% |
| Vermont | 13 of 14 | 92.9% |
| Virginia | 97 of 144 | 67.4% |
| Washington | 65 of 114 | 57% |
| West Virginia | 55 of 69 | 79.7% |
| Wisconsin | 68 of 96 | 70.8% |
| Wyoming | 11 of 13 | 84.6% |
Medicare Part D paid for 401,741 30-day fills of NovoLog Mix in 2024 for about 58,637 enrollees, at an average total cost of $163.70 per 30-day fill (CMS Part D Prescribers by Geography and Drug, national).
Price NovoLog Mix and the rest of a client's list on every plan in their county.
Estimate NovoLog Mix costs by plan
Free tools for licensed insurance agents. Data from CMS public files; verify with plan documents before advising a client.
Counts are over every Medicare Advantage drug plan and stand-alone Part D plan in the CMS monthly formulary files, excluding employer plans. A plan counts as covering a drug when any strength or form of it is on the plan’s formulary; the tier, prior authorization, step therapy and quantity limit shown are the most favorable version on that formulary. Copays are for a 30-day supply at a preferred retail pharmacy after the deductible. This is a reference for licensed agents, not a plan recommendation; verify with the plan’s formulary before advising a client. Source: CMS Part D formulary files (release 10/08/2026). CMS formulary data.